Unichem Labs Pithampur facility gets USFDA EIR
Mumbai: Unichem Labs has announced that United States Food and Drug Administration (USFDA) has classified the inspection at the Company's Pithampur API facility as Voluntary Action Initiated ("VAI") and issued the Establishment Inspection Report (EIR).
The facility was inspected from 24th February 2025 to 28th February 2025. In March, the facility had initially received four observations from the USFDA.
Read also: Unichem Labs Pithampur API facility gets 4 USFDA observations
Voluntary Action Indicated (VAI) classification indicates the inspection found objectionable conditions or practices but the agency has determined the facility can voluntarily correct its deficiencies and will not recommend any action.
Headquartered in Mumbai, Unichem Laboratories Limited is an international, integrated, specialty pharmaceutical company. The company was founded in 1944 by Padmabhushan Late Mr. Amrut V Mody. It manufactures and markets a large basket of pharmaceutical formulations as branded generics as well as generics in several markets across the world.
Read also: Sandip Ghume to resign as Unichem Labs Deputy CFO, Key Managerial Personnel
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.